发明申请
US20160015682A2 TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS
审中-公开
四氯胞嘧啶（THCV）用于保护胰岛细胞
- 专利标题： TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS
- 专利标题（中）： 四氯胞嘧啶（THCV）用于保护胰岛细胞
-
申请号： US14358861申请日： 2012-11-20
-
公开(公告)号： US20160015682A2公开(公告)日： 2016-01-21
- 发明人: Michael Cawthorne , Colin Stott , Stephen Wright
- 申请人： Michael Cawthorne , Colin Stott , Stephen Wright
- 申请人地址： GB Salisbury
- 专利权人： GW Pharma Limited
- 当前专利权人： GW Pharma Limited
- 当前专利权人地址： GB Salisbury
- 优先权： GB1120066.4 20111121
- 国际申请： PCT/GB2012/052869 WO 20121120
- 主分类号： A61K31/352
- IPC分类号： A61K31/352 ; A61K45/06 ; A61K31/4439 ; A61K36/185
摘要：
The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient.
公开/授权文献
信息查询
